title: Women's views on postpartum testing for type 2 diabetes after gestational diabetes: Six month follow-up to the DIAMIND randomised controlled trial.
abstract: BACKGROUND
  This study assessed the views of the women who participated in the DIAMIND randomised trial of postpartum SMS reminders to test for type 2 diabetes after gestational diabetes (GDM) on their preferred type of postpartum reminder system and barriers and facilitators to completion of postpartum diabetes testing.
  
  
  METHODS
  A written questionnaire was sent to women with recent GDM who participated in the DIAMIND trial (n=276) via post or email at six months after the birth of their baby.
  
  
  RESULTS
  208 women (75%) returned the study questionnaires. Preferred postpartum reminder types were: SMS (67%), email (17%), postal (12%) and voice call (1%). Women who had not yet completed an OGTT indicated that they planned to undertake one in the future (61%). Common barriers to postpartum OGTT completion included: not having enough time (73%), inadequate childcare (30%), and a need to focus on the health of the baby (30%). The most common facilitator was having a shorter test (33%).
  
  
  CONCLUSIONS
  Improved childcare quality and access as well as more research into a shorter, more convenient test procedure for type 2 diabetes screening are needed. Reminder systems for postpartum diabetes screening should be electronic where possible.
authors: Robinson Research Institute, The University of Adelaide, Adelaide, Australia. Electronic address: emer.vanryswyk@adelaide.edu.au.
authors: E M
authors: EM
authors: Van Ryswyk
authors: Robinson Research Institute, The University of Adelaide, Adelaide, Australia. Electronic address: philippa.middleton@adelaide.edu.au.
authors: P F
authors: PF
authors: Middleton
authors: Robinson Research Institute, The University of Adelaide, Adelaide, Australia. Electronic address: bill.hague@adelaide.edu.au.
authors: W M
authors: WM
authors: Hague
authors: Robinson Research Institute, The University of Adelaide, Adelaide, Australia; Liggins Institute, The University of Auckland, Auckland, New Zealand. Electronic address: caroline.crowther@adelaide.edu.au.
authors: C A
authors: CA
authors: Crowther
mesh_terms: D000328:Adult; D001315:Australia; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D015709:Correspondence as Topic; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis*; D016640:Diabetes, Gestational / Q000175:diagnosis*; D034742:Electronic Mail; D005260:Female; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007223:Infant; D007224:Infant Care; D007231:Infant, Newborn; D010342:Patient Acceptance of Health Care; D057240:Patient Preference; D011181:Postnatal Care / Q000379:methods*; D011247:Pregnancy; D017010:Reminder Systems; D011795:Surveys and Questionnaires; D013689:Telephone; D060145:Text Messaging; D013997:Time Factors
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human
keywords: Australian New Zealand Clinical Trials Registry—ACTRN12612000621819; Gestational diabetes mellitus; Postpartum care; Screening; Type 2 diabetes; Women's views